BRUNELLI, SILVIA
 Distribuzione geografica
Continente #
NA - Nord America 7.124
EU - Europa 3.177
AS - Asia 971
AF - Africa 7
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 5
OC - Oceania 1
Totale 11.291
Nazione #
US - Stati Uniti d'America 7.008
DE - Germania 732
IT - Italia 683
CN - Cina 442
SE - Svezia 440
IE - Irlanda 324
UA - Ucraina 306
SG - Singapore 227
RU - Federazione Russa 165
GB - Regno Unito 158
HK - Hong Kong 142
CA - Canada 115
FR - Francia 103
FI - Finlandia 91
VN - Vietnam 59
DK - Danimarca 41
AT - Austria 29
IN - India 29
NL - Olanda 26
BE - Belgio 22
TR - Turchia 20
ID - Indonesia 18
JP - Giappone 18
BG - Bulgaria 14
PL - Polonia 13
CZ - Repubblica Ceca 10
IR - Iran 7
ES - Italia 6
CH - Svizzera 5
EU - Europa 4
RE - Reunion 4
CL - Cile 3
TW - Taiwan 3
GR - Grecia 2
KR - Corea 2
PK - Pakistan 2
RO - Romania 2
ZA - Sudafrica 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
AU - Australia 1
BR - Brasile 1
HR - Croazia 1
HU - Ungheria 1
LK - Sri Lanka 1
MK - Macedonia 1
MX - Messico 1
MY - Malesia 1
NO - Norvegia 1
RS - Serbia 1
SC - Seychelles 1
VE - Venezuela 1
Totale 11.291
Città #
Ann Arbor 1.655
Woodbridge 743
Fairfield 703
Frankfurt am Main 638
Houston 564
Wilmington 417
Ashburn 394
Jacksonville 345
Chandler 337
Dublin 309
Seattle 276
Cambridge 241
Milan 217
Dearborn 186
Singapore 166
Hong Kong 141
Princeton 137
New York 131
Nanjing 101
Shanghai 77
Lawrence 67
Lachine 59
Altamura 58
Beijing 49
Santa Clara 35
Helsinki 32
Nanchang 32
Ottawa 30
San Diego 30
Andover 29
Vienna 29
Boardman 28
Dong Ket 26
Hebei 23
Paris 22
Mountain View 21
Shenyang 20
Fremont 18
Jakarta 18
Chicago 17
Rome 17
Brembate 16
Brussels 16
Jiaxing 16
London 15
Guangzhou 14
Norwalk 14
Changsha 13
Falls Church 13
Los Angeles 13
Kraków 12
Plovdiv 12
Redmond 12
Bonndorf 11
Jinan 11
Kunming 11
Turin 11
Zhengzhou 10
Dallas 9
Hefei 9
Philadelphia 9
Tianjin 9
Toronto 9
Brno 8
Edmonton 8
Hangzhou 8
Taizhou 8
Brescia 7
Huizen 7
Monza 7
University Park 7
Auburn Hills 6
Bergamo 6
Cinisello Balsamo 6
Como 6
Kocaeli 6
Pisogne 6
Tappahannock 6
Washington 6
Bottanuco 5
Castrovillari 5
Frontino 5
Genoa 5
Phoenix 5
San Mateo 5
Tokyo 5
Brugherio 4
Carate Brianza 4
Deinze 4
Duncan 4
Florence 4
Laurel 4
Leiden 4
Lissone 4
Lleida 4
Montréal 4
Muggiò 4
Nicosia 4
Ningbo 4
Saint-Denis 4
Totale 8.902
Nome #
Macrophages Guard Endothelial Lineage by Hindering Endothelial-to-Mesenchymal Transition: Implications for the Pathogenesis of Systemic Sclerosis 365
Nitric oxide donor molsidomine positively modulates myogenic differentiation of embryonic endothelial progenitors 364
Prenatal Origin of Pediatric Leukemia: Lessons From Hematopoietic Development 336
Severe Heterotopic Ossification in the Skeletal Muscle and Endothelial Cells Recruitment to Chondrogenesis Are Enhanced by Monocyte/Macrophage Depletion 334
Necdin Enhances Myoblasts Survival by Facilitating the Degradation of the Mediator of Apoptosis CCAR1/CARP1 305
High mobility group box 1 orchestrates tissue regeneration via CXCR4 297
Gastric cancer does not affect the expression of atrophy-related genes in human skeletal muscle 284
Induction of acute skeletal muscle regeneration by cardiotoxin injection 278
Rebalancing expression of HMGB1 redox isoforms to counteract muscular dystrophy 261
Study protocol: understanding the pathophysiologic mechanisms underlying delirium in older people undergoing hip fracture surgery 250
Mesenchymal Transitions in Development and Disease 223
Cripto shapes macrophage plasticity and restricts EndMT in injured and diseased skeletal muscle 218
Editorial: Fetal/Embryonic Hematopoietic Progenitors and Their Impact on Adult Diseases 218
Vascular Remodelling and Mesenchymal Transition in Systemic Sclerosis 209
The immune system and the repair of skeletal muscle 197
Impaired generation of mature neurons by neural stem cells from hypomorphic Sox2 mutants 195
High-throughput screening for modulators of ACVR1 transcription: Discovery of potential therapeutics for fibrodysplasia ossificans progressiva 190
One Size Does Not Fit All: Heterogeneity in Developmental Hematopoiesis 183
MeCP2 affects skeletal muscle growth and morphology through non cell-autonomous mechanisms 182
Inflammatory and alternatively activated human macrophages attract vessel-associated stem cells, relying on separate HMGB1- and MMP-9-dependent pathways 178
Necdin mediates skeletal muscle regeneration by promoting myoblast survival and differentiation. 177
Skeletal muscle of gastric cancer patients expresses genes involved in muscle regeneration 177
Follistatin induction by nitric oxide through cyclic GMP: a tightly regulated signaling pathway that controls myoblast fusion 170
Necdin enhances muscle reconstitution of dystrophic muscle by vessel-associated progenitors, by promoting cell survival and myogenic differentiation 164
Cardiac mesoangioblasts are committed, self-renewable progenitors, associated with small vessels of juvenile mouse ventricle 163
Biological heterogeneity of putative bladder cancer stem-like cell populations from human bladder transitional cell carcinoma samples 163
Muscle-specific Drp1 overexpression impairs skeletal muscle growth via translational attenuation 162
Binding of sFRP-3 to EGF in the extra-cellular space affects proliferation, differentiation and morphogenetic events regulated by the two molecules 161
Complete repair of dystrophic skeletal muscle by mesoangioblasts with enhanced migration ability 155
HuR and miR-1192 regulate myogenesis by modulating the translation of HMGB1 mRNA 155
Nitric oxide: emerging concepts about its use in cell-based therapies 153
Beta catenin-independent activation of MyoD in presomitic mesoderm requires PKC and depends on Pax3 transcriptional activity 152
Skeletal Muscle Differentiation Of Embryonic Mesoangioblasts Requires Pax3 Activity 148
Pax3:Foxc2 Reciprocal Repression in the Somite Modulates Muscular versus Vascular Cell Fate Choice in Multipotent Progenitors 148
Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo 148
Necdin is expressed in cachectic skeletal muscle to physiologically protect fibers from tumor-induced wasting 146
Vessel-associated myogenic precursors control macrophage activation and clearance of apoptotic cells 146
Cell death: tipping the balance of autoimmunity and tissue repair 145
Ex vivo treatment with nitric oxide increases mesoangioblast therapeutic efficacy in muscular dystrophy 144
Genetic and Acquired Heterotopic Ossification: A Translational Tale of Mice and Men 142
Remodeling of the chromatin structure of the facioscapulohumeral muscular dystrophy (FSHD) locus and upregulation of FSHD-related gene 1 (FRG1) expression during human myogenic differentiation 141
Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells 137
Sphingosine 1-phosphate mediates proliferation and survival of mesoangioblasts. 136
Hemogenic endothelium generates mesoangioblasts that contribute to several mesodermal lineages in vivo 134
A role for MSX2 and necdin in smooth muscle differentiation of mesoangioblasts and other mesoderm progenitor cells 133
Co-administration of ibuprofen and nitric oxide is an effective experimental therapy for muscular dystrophy, with immediate applicability to humans 133
Nitric Oxide Sustains Long-Term Skeletal Muscle Regeneration by Regulating Fate of Satellite Cells Via Signaling Pathways Requiring Vangl2 and Cyclic GMP 131
Intracellular Inactivation of Thyroid Hormone Is a Survival Mechanism for Muscle Stem Cell Proliferation and Lineage Progression 131
Nitric oxide release combined with nonsteroidal antiinflammatory activity prevents muscular dystrophy pathology and enhances stem cell therapy 130
Macrophage Plasticity in Skeletal Muscle Repair 130
ADAP2 in heart development: A candidate gene for the occurrence of cardiovascular malformations in NF1 microdeletion syndrome 130
The low affinity receptor for neurotrophins p75NTR plays a key role for satellite cell function in muscle repair acting via RhoA. Molecular Biology of the Cell 128
A dual acting compound releasing nitric oxide (NO) and ibuprofen, NCX 320, shows significant therapeutic effects in a mouse model of muscular dystrophy 124
The nitric oxide-donor molsidomine modulates the innate inflammatory response in a mouse model of muscular dystrophy 124
Hematopoietic Stem Cell (HSC)-Independent Progenitors Are Susceptible to Mll-Af9-Induced Leukemic Transformation 123
Macrophages commit postnatal endothelium-derived progenitors to angiogenesis and restrict endothelial to mesenchymal transition during muscle regeneration 122
Polarization dictates iron handling by inflammatory and alternatively activated macrophages 118
Cripto regulates skeletal muscle regeneration and modulates satellite cell determination by antagonizing myostatin 115
Nitric oxide donor and non steroidal anti inflammatory drugs as a therapy for muscular dystrophies: Evidence from a safety study with pilot efficacy measures in adult dystrophic patients 113
Requirement of inducible nitric oxide synthase for skeletal muscle regeneration after acute damage 108
Transplanted mesoangioblasts require macrophage IL-10 for survival in a mouse model of muscle injury 104
Sphingosine 1-phosphate induces differentiation of mesoangioblasts towards smooth muscle. A role for GATA6 101
Regulation of mitochondrial dynamics by nitric oxide is a key event in myogenesis 101
High-mobility group box 1 release and redox regulation accompany regeneration and remodeling of skeletal muscle 100
Nitric Oxide drives embryonic myogenesis in chicken through the upregulation of myogenic differentiation factors 98
Nitric oxide inhibition of Drp1-mediated mitochondrial fission is critical for myogenic differentiation 96
Human cardiac mesoangioblasts isolated from hypertrophic cardiomyopathies are greatly reduced in proliferation and differentiation potency 94
null 90
Mesoangioblasts at 20: From the embryonic aorta to the patient bed 76
TGFbeta protects mesoangioblasts from apoptosis via sphingosine kinase-1 regulation 68
Cellular interactions and microenvironment dynamics in skeletal muscle regeneration and disease 22
Nitric oxide and muscle repair: Multiple actions converging on therapeutic efficacy 17
Totale 11.694
Categoria #
all - tutte 35.172
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 35.172


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.877 0 0 174 215 229 240 304 180 237 97 139 62
2020/20211.784 95 73 146 186 162 136 178 129 152 220 123 184
2021/20221.270 103 117 195 114 93 117 50 50 41 62 132 196
2022/20231.965 220 567 234 152 161 275 20 94 111 23 56 52
2023/20241.196 58 79 41 69 179 263 227 54 82 11 12 121
2024/2025449 156 236 57 0 0 0 0 0 0 0 0 0
Totale 11.694